JP2005511015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511015A5 JP2005511015A5 JP2003523605A JP2003523605A JP2005511015A5 JP 2005511015 A5 JP2005511015 A5 JP 2005511015A5 JP 2003523605 A JP2003523605 A JP 2003523605A JP 2003523605 A JP2003523605 A JP 2003523605A JP 2005511015 A5 JP2005511015 A5 JP 2005511015A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- seq
- nrp
- ala
- sequence number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31495201P | 2001-08-24 | 2001-08-24 | |
| PCT/US2002/026782 WO2003018754A2 (en) | 2001-08-24 | 2002-08-22 | Neural regeneration peptide and methods for their use in treatment of brain damage |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511015A JP2005511015A (ja) | 2005-04-28 |
| JP2005511015A5 true JP2005511015A5 (https=) | 2006-01-05 |
| JP4399260B2 JP4399260B2 (ja) | 2010-01-13 |
Family
ID=23222205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003523605A Expired - Fee Related JP4399260B2 (ja) | 2001-08-24 | 2002-08-22 | 神経再生ペプチドおよび脳損傷治療におけるその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7767786B2 (https=) |
| EP (2) | EP2382982A3 (https=) |
| JP (1) | JP4399260B2 (https=) |
| AU (1) | AU2002335657A1 (https=) |
| WO (1) | WO2003018754A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070004641A1 (en) * | 2001-05-24 | 2007-01-04 | Neuren Pharmaceuticals Limited | Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate |
| US7714020B2 (en) | 2001-05-24 | 2010-05-11 | Neuren Pharmaceuticals Limited | Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate |
| EP1401808B1 (en) | 2001-05-24 | 2009-07-08 | Neuren Pharmaceuticals Limited | Gpe analogs and peptidomimetics |
| US7605177B2 (en) * | 2001-05-24 | 2009-10-20 | Neuren Pharmaceuticals Limited | Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration |
| JP3983260B2 (ja) | 2003-07-09 | 2007-09-26 | 塩野義製薬株式会社 | アトピー性皮膚炎誘引物質 |
| WO2005042561A2 (en) * | 2003-10-31 | 2005-05-12 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods of use |
| EP1779867A4 (en) * | 2004-07-01 | 2009-12-02 | Eisai R&D Man Co Ltd | MEANS FOR PROMOTING NERVE REVENERATION |
| JP4988711B2 (ja) * | 2005-05-06 | 2012-08-01 | クロンズ ホールディングズ カンパニー リミテッド | 神経再生ペプチド及びそれを含む処方物 |
| WO2009051844A1 (en) | 2007-10-17 | 2009-04-23 | Neuren Pharmaceuticals Limited | Synthetic analogues of neural regeneration peptides |
| US9259432B1 (en) | 2011-01-31 | 2016-02-16 | Parminder J. S. Vig | Composition and methods for targeted delivery of a therapeutic compound to the brain or spinal cord of a subject for treatment of neurodegenerative diseases |
| US20140018299A1 (en) * | 2012-07-10 | 2014-01-16 | Banyan Biomarkers, Inc. | Method and device to detect, monitor and promote neural regeneration and improvement of cognitive function in a subject suffering from neural injury |
| KR20160065969A (ko) * | 2013-10-11 | 2016-06-09 | 타릭스 파마슈티컬스 엘티디. | 신규 펩티드 조성물 |
| CN119080877B (zh) * | 2024-10-11 | 2025-09-23 | 完美（广东）日用品有限公司 | 一种低聚肽及其在制备减脂制品中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| JPS58118008A (ja) | 1982-01-06 | 1983-07-13 | Nec Corp | デ−タ処理装置 |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3483949D1 (de) | 1983-09-26 | 1991-02-21 | Udo Dr Med Ehrenfeld | Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr. |
| DE3474511D1 (en) | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| EP0721464A4 (en) * | 1993-09-01 | 1998-12-30 | Start Technology Partnership | NEURON REGULATOR FACTOR FOR PROMOTING NEURON SURVIVAL |
| WO1995032003A1 (en) | 1994-05-24 | 1995-11-30 | Amgen Boulder Inc. | Modified insulin-like growth factors |
| US5834192A (en) * | 1996-04-05 | 1998-11-10 | Incyte Pharmaceuticals, Inc. | Human cachexia associated protein |
| AU4199597A (en) * | 1996-09-09 | 1998-04-02 | Novo Nordisk A/S | A cdna and peptide with relation to cancer and weight loss |
| NZ504669A (en) * | 1997-11-25 | 2002-11-26 | Gen Hospital Corp | Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents |
| WO1999051736A1 (en) * | 1998-04-03 | 1999-10-14 | Mcp Hahnemann University | Neuron regulatory factor comprising a small peptide for promoting neuron survival |
| US7563862B2 (en) * | 2001-08-24 | 2009-07-21 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods for their use in treatment of brain damage |
-
2002
- 2002-08-22 AU AU2002335657A patent/AU2002335657A1/en not_active Abandoned
- 2002-08-22 EP EP11158040A patent/EP2382982A3/en not_active Withdrawn
- 2002-08-22 WO PCT/US2002/026782 patent/WO2003018754A2/en not_active Ceased
- 2002-08-22 EP EP02770419A patent/EP1572887A4/en not_active Withdrawn
- 2002-08-22 US US10/225,838 patent/US7767786B2/en not_active Expired - Lifetime
- 2002-08-22 JP JP2003523605A patent/JP4399260B2/ja not_active Expired - Fee Related
-
2010
- 2010-08-03 US US12/849,681 patent/US20110306557A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5512661A (en) | Multitrophic and multifunctional chimeric neurotrophic factors | |
| US7563862B2 (en) | Neural regeneration peptides and methods for their use in treatment of brain damage | |
| US5888762A (en) | Neurotropic growth factors comprising a homeobox peptide | |
| US20110306557A1 (en) | Neural regeneration peptides and methods for their use in treatment of brain damage | |
| JP2005511015A5 (https=) | ||
| US6084069A (en) | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy | |
| US6511823B1 (en) | Heparin binding neurotrophic factor gene sequence | |
| US5210026A (en) | Human mk gene and method of expression | |
| AU2002364727B2 (en) | Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 | |
| Chen et al. | Human glial cell-line-derived neurotrophic factor: a structure–function analysis | |
| JP2001514487A (ja) | 酸性感受性哺乳動物ニュ−ロン陽イオンチャンネル、そのクロ−ニングおよびその用途 | |
| JP5026083B2 (ja) | 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法 | |
| AU706565B2 (en) | Human netrin-1 | |
| WO2006028497A2 (en) | Active recombinant human lysozyme | |
| US5489514A (en) | DNA coding for growth-inhibitory factor and use thereof | |
| EP0535336A2 (en) | MK protein as cell growth inhibitor | |
| EP0535337A2 (en) | Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor | |
| CA2236001C (en) | Biologically active eph family ligands | |
| AU713198B2 (en) | Cloning, expression and uses of a novel secreted protein, F-spondin | |
| JP3131770B2 (ja) | 神経突起伸長活性を有する蛋白質 | |
| JP4677319B2 (ja) | 神経分化抑制ペプチド及びその利用 | |
| JPH10201477A (ja) | 蛋白質ｓａｐａｐ１ | |
| JPH10201478A (ja) | 蛋白質ｓａｐａｐ２ | |
| WO2004001038A1 (ja) | 細胞または組織の神経化に関与する新規遺伝子およびタンパク質、並びにその利用 | |
| JPH06340697A (ja) | 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのポリペプチドまたは抗体を含有する薬学的組成物 |